Black Men Should Be Screened Earlier for Prostate Cancer Black Men Should Be Screened Earlier for Prostate Cancer
Compared with white men, black men develop preclinical prostate cancer at an earlier age and face a higher risk of metastatic progression, researchers report.Reuters Health Information (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - April 27, 2017 Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news
Electromagnetic Guidance System Facilitates Percutaneous Kidney Access Electromagnetic Guidance System Facilitates Percutaneous Kidney Access
A novel electromagnetic guidance system facilitates ureteroscopy-assisted percutaneous kidney access, researchers from Portugal report.Reuters Health Information (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - April 20, 2017 Category: Urology & Nephrology Tags: Nephrology News Source Type: news
Cancer Incidence Differs Between African- and U.S.-born Blacks Cancer Incidence Differs Between African- and U.S.-born Blacks
The incidence of various types of cancers differs significantly between blacks born in the United States and Sub-Saharan African-born blacks living in the U.S., researchers say.Reuters Health Information (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - April 18, 2017 Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news
' Individualize' Prostate Cancer Screening, Says USPSTF'Individualize' Prostate Cancer Screening, Says USPSTF
In an update to prostate screening guidance, the task force says that for men from 55 to 69 years of age, the decision to screen must be an individual one.Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - April 11, 2017 Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news
Men Who Use Aspirin Regularly Have Lower Risk of Lethal Prostate Cancer Men Who Use Aspirin Regularly Have Lower Risk of Lethal Prostate Cancer
Men who have used aspirin regularly face a lower risk of lethal prostate cancer than men who haven ’ t, according to findings from the Physicians ’ Health Study (PHS).Reuters Health Information (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - March 6, 2017 Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news
Photodynamic Therapy for Prostate Cancer Shows Early Promise Photodynamic Therapy for Prostate Cancer Shows Early Promise
Initial study results using photodynamic therapy for shrinking prostate cancer size are promising and demonstrate the need for studies with longer follow-up and larger study groups.Medscape Urology (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - February 24, 2017 Category: Urology & Nephrology Tags: Urology Commentary Source Type: news
Few Transgender Teens Opt for Fertility Preservation Few Transgender Teens Opt for Fertility Preservation
Just a fraction of transgender adolescents who are counseled about infertility risks associated with their treatment will opt for fertility preservation (FP) measures, new research shows.Reuters Health Information (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - February 10, 2017 Category: Urology & Nephrology Tags: Diabetes & Endocrinology News Source Type: news
Alternative Medicine Might Help Treat Premature Ejaculation Alternative Medicine Might Help Treat Premature Ejaculation
Complementary and alternative medicine options may help men manage premature ejaculation, according to a new review of existing research.Reuters Health Information (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - January 30, 2017 Category: Urology & Nephrology Tags: Urology News Source Type: news
Periodontitis Tied to Risk of Erectile Dysfunction Periodontitis Tied to Risk of Erectile Dysfunction
Erectile dysfunction is more common in men with chronic gum disease, according to a new review of existing studies.Reuters Health Information (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - December 1, 2016 Category: Urology & Nephrology Tags: Urology News Source Type: news
Spectrum Pharma Says U.S. FDA Rejects Its Bladder Cancer Drug Spectrum Pharma Says U.S. FDA Rejects Its Bladder Cancer Drug
Spectrum Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration had rejected the drugmaker ' s bladder cancer treatment, apaziquone.Reuters Health Information (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - November 23, 2016 Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news
Vasectomies Not Linked to Higher Prostate Cancer Risk Vasectomies Not Linked to Higher Prostate Cancer Risk
Having a vasectomy doesn ' t increase a man ' s risk of developing prostate cancer or dying from it, a Canadian study suggests.Reuters Health Information (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - November 11, 2016 Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news
PSA Testing: A New, Simpler Way? PSA Testing: A New, Simpler Way?
Dr Chodak reviews a new algorithm intended to simplify PSA testing. But is it ready for prime time?Medscape Urology (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - November 7, 2016 Category: Urology & Nephrology Tags: Urology Commentary Source Type: news
Many Recover Erectile, Urinary Function After Prostatectomy Many Recover Erectile, Urinary Function After Prostatectomy
Patients with urinary incontinence (UI) or erectile dysfunction (ED) 12 months after radical prostatectomy (RP) have a good chance of functional recovery by 36 months, new research confirms.Reuters Health Information (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - October 27, 2016 Category: Urology & Nephrology Tags: Urology News Source Type: news
FDA Panel Backs Allergan's Drug for Frequent Nightly Urination FDA Panel Backs Allergan's Drug for Frequent Nightly Urination
The benefits associated with Allergan Plc ' s experimental drug to treat frequent nightly urination outweigh the risks for certain patients, an advisory panel to the U.S. Food and Drug Administration concluded on Wednesday.Reuters Health Information (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - October 20, 2016 Category: Urology & Nephrology Tags: Pharmacist News Source Type: news
Immunotherapy'Altering the Landscape' for Bladder Cancer Immunotherapy'Altering the Landscape' for Bladder Cancer
Two more immunotherapies, nivolumab and pembrolizumab, have shown activity in bladder cancer and look set to join atezolizumab.Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - October 10, 2016 Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news
